2005
DOI: 10.1007/s10555-005-6193-1
|View full text |Cite
|
Sign up to set email alerts
|

Prokaryotic expression of antibodies

Abstract: Maximizing the expression yields of recombinant whole antibodies and antibody fragments such as Fabs, single-chain Fvs and single-domain antibodies is highly desirable since it leads to lower production costs. Various eukaryotic and prokaryotic expression systems have been exploited to accommodate antibody expression but Escherichia coli systems have enjoyed popularity, in particular with respect to antibody fragments, because of their low cost and convenience. In many instances, product yields have been less … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
83
0
4

Year Published

2007
2007
2017
2017

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 164 publications
(88 citation statements)
references
References 189 publications
(160 reference statements)
1
83
0
4
Order By: Relevance
“…Bacteria can be used to display on their surface antibodies of different format for diagnostic applications [8,9] and to obtain elevated VHH productions in both the periplasm and the cytoplasm [10][11][12][13]. In contrast, the yields of reconstituted IgG-like molecules and fusions with some valuable tags remain low [14,15] due to either structural complexity or different redox requirements of the two partner polypeptides.…”
Section: Introductionmentioning
confidence: 99%
“…Bacteria can be used to display on their surface antibodies of different format for diagnostic applications [8,9] and to obtain elevated VHH productions in both the periplasm and the cytoplasm [10][11][12][13]. In contrast, the yields of reconstituted IgG-like molecules and fusions with some valuable tags remain low [14,15] due to either structural complexity or different redox requirements of the two partner polypeptides.…”
Section: Introductionmentioning
confidence: 99%
“…Nanobody GFP is a single domain antibody fragment (VHH) derived from a llama antibody that binds to GFP with nanomolar affinity and has been described under several different names including GFP--binding protein 1 (GBP1), Enhancer and GFP--nanobody [29,36,37,42]. Solubility tags similar to His6--SUMO are known to facilitate high--level expression of nanobodies in the cytoplasm of E. coli [43]. Since oxidation of the single cysteine pair in the structure of the nanobody cannot normally take place in the reducing cytoplasm, we coexpressed sulfhydryl oxidase Erv1 and a disulfide isomerase DsbC from plasmid pMJS10 [30] together with His6--SUMO--Nanobody GFP in BL21--SI cells.…”
Section: Expression and Purification Of Functional Nanobody Gfpmentioning
confidence: 99%
“…On the contrary, ScFv can be readily produced in bacterial cells, in particular Escherichia coli (E. coli), often as inclusion bodies (IBs) [30][31][32][33][34]. When expressed as IBs, solubilization and subsequent refolding of the insoluble proteins are required for production of functional and soluble proteins.…”
Section: Introductionmentioning
confidence: 99%